4D MOLECULAR THERAPEUTICS IN (FDMT) Stock News
USA - NASDAQ:FDMT - US35104E1001 - Common Stock
11.84 USD
+1.84 (+18.4%)
FDMT Latest News, Press Relases and Analysis
All
Press Releases
3 days ago - By: Benzinga
7 days ago - By: 4D Molecular Therapeutics, Inc.
7 days ago - By: 4D Molecular Therapeutics, Inc.
10 days ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: Benzinga
10 days ago - By: 4D Molecular Therapeutics, Inc.
11 days ago - By: 4D Molecular Therapeutics, Inc.
11 days ago - By: 4D Molecular Therapeutics, Inc.
a month ago - By: 4D Molecular Therapeutics, Inc.
a month ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: Zacks Investment Research - Mentions: SPRY
2 months ago - By: The Motley Fool
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.